ID   PC-3/IF
AC   CVCL_E7UP
SY   PC-3/IntraFemoral
RX   PubMed=9717832;
WW   Provider; WSU OTC; 98-448; http://wayne.technologypublisher.com/technology/5217
CC   Population: Caucasian.
CC   Characteristics: Established from a tumor produced in nude mice following intrafemoral injection of the parent cell line (PubMed=9717832).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=9717832;
RA   Triest J.A., Grignon D.J., Cher M.L., Kocheril S.V., Montecillo E.J.,
RA   Talati B., Tekyi-Mensah S., Pontes J.E., Hillman G.G.;
RT   "Systemic interleukin 2 therapy for human prostate tumors in a nude
RT   mouse model.";
RL   Clin. Cancer Res. 4:2009-2014(1998).
//